{"entity":{"type":"insider","cik":"0001861878","url":"/insider/0001861878","json_url":"/insider/0001861878.json","name":"YVER ANTOINE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2022-05-19","last":"2023-06-02","span_basis":"filed_date"},"name_variants":[{"name":"YVER ANTOINE","source":"filing","n_filings":16,"first_seen":"2022-05-19","last_seen":"2023-06-02"}],"transactions":[{"id":8490761,"accession":"0001847903-23-000104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-23-000104","line_url":"/filing/0001847903-23-000104#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":4.4537,"price_display":"4.45","price_state":"stated","total_value":28949.05,"total_display":"28,949.05","shares_owned_after":783066.0,"shares_owned_after_display":"783,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":7912057,"accession":"0001847903-23-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-23-000090","line_url":"/filing/0001847903-23-000090#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":4.424,"price_display":"4.42","price_state":"stated","total_value":30083.2,"total_display":"30,083.20","shares_owned_after":789566.0,"shares_owned_after_display":"789,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8380359,"accession":"0001847903-23-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-23-000082","line_url":"/filing/0001847903-23-000082#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":3.691,"price_display":"3.69","price_state":"stated","total_value":24729.7,"total_display":"24,729.70","shares_owned_after":796366.0,"shares_owned_after_display":"796,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-04","scope":"insider"},{"id":8418184,"accession":"0001847903-23-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-23-000054","line_url":"/filing/0001847903-23-000054#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":3.4243,"price_display":"3.42","price_state":"stated","total_value":23970.1,"total_display":"23,970.10","shares_owned_after":806681.0,"shares_owned_after_display":"806,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":8595506,"accession":"0001847903-23-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-23-000045","line_url":"/filing/0001847903-23-000045#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":3.7923,"price_display":"3.79","price_state":"stated","total_value":29200.71,"total_display":"29,200.71","shares_owned_after":813681.0,"shares_owned_after_display":"813,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":8029916,"accession":"0001847903-23-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-23-000016","line_url":"/filing/0001847903-23-000016#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6970.0,"shares_display":"6,970","price_per_share":3.1759,"price_display":"3.18","price_state":"stated","total_value":22136.023,"total_display":"22,136.02","shares_owned_after":751913.0,"shares_owned_after_display":"751,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-04","scope":"insider"},{"id":6910683,"accession":"0001847903-22-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000109","line_url":"/filing/0001847903-22-000109#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9400.0,"shares_display":"9,400","price_per_share":3.9089,"price_display":"3.91","price_state":"stated","total_value":36743.66,"total_display":"36,743.66","shares_owned_after":761151.0,"shares_owned_after_display":"761,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6261490,"accession":"0001847903-22-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000076","line_url":"/filing/0001847903-22-000076#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":4.0263,"price_display":"4.03","price_state":"stated","total_value":39055.11,"total_display":"39,055.11","shares_owned_after":765059.0,"shares_owned_after_display":"765,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":9296465,"accession":"0001847903-22-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000096","line_url":"/filing/0001847903-22-000096#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":3.9061,"price_display":"3.91","price_state":"stated","total_value":37107.95,"total_display":"37,107.95","shares_owned_after":780251.0,"shares_owned_after_display":"780,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-11-23","scope":"insider"},{"id":6363767,"accession":"0001847903-22-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-22-000065","line_url":"/filing/0001847903-22-000065#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12524.0,"shares_display":"12,524","price_per_share":3.9167,"price_display":"3.92","price_state":"stated","total_value":49052.7508,"total_display":"49,052.75","shares_owned_after":774759.0,"shares_owned_after_display":"774,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6363766,"accession":"0001847903-22-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000065","line_url":"/filing/0001847903-22-000065#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2468.0,"shares_display":"2,468","price_per_share":4.0674,"price_display":"4.07","price_state":"stated","total_value":10038.3432,"total_display":"10,038.34","shares_owned_after":787283.0,"shares_owned_after_display":"787,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":6945122,"accession":"0000899243-22-030302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030302","line_url":"/filing/0000899243-22-030302#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10423.0,"shares_display":"10,423","price_per_share":4.4121,"price_display":"4.41","price_state":"stated","total_value":45987.3183,"total_display":"45,987.32","shares_owned_after":789751.0,"shares_owned_after_display":"789,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-02","scope":"insider"},{"id":6117699,"accession":"0000899243-22-027633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-027633","line_url":"/filing/0000899243-22-027633#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10423.0,"shares_display":"10,423","price_per_share":4.4522,"price_display":"4.45","price_state":"stated","total_value":46405.2806,"total_display":"46,405.28","shares_owned_after":800174.0,"shares_owned_after_display":"800,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6414473,"accession":"0000899243-22-026421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-026421","line_url":"/filing/0000899243-22-026421#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":4.8656,"price_display":"4.87","price_state":"stated","total_value":97312.0,"total_display":"97,312.00","shares_owned_after":810597.0,"shares_owned_after_display":"810,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6841184,"accession":"0000899243-22-025479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-025479","line_url":"/filing/0000899243-22-025479#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":5.0326,"price_display":"5.03","price_state":"stated","total_value":45796.66,"total_display":"45,796.66","shares_owned_after":730597.0,"shares_owned_after_display":"730,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6341861,"accession":"0000899243-22-023485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-023485","line_url":"/filing/0000899243-22-023485#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":4.6778,"price_display":"4.68","price_state":"stated","total_value":43035.76,"total_display":"43,035.76","shares_owned_after":739697.0,"shares_owned_after_display":"739,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":6117456,"accession":"0000899243-22-018913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018913","line_url":"/filing/0000899243-22-018913#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64778.0,"shares_display":"64,778","price_per_share":5.0959,"price_display":"5.10","price_state":"stated","total_value":330102.2102,"total_display":"330,102.21","shares_owned_after":748897.0,"shares_owned_after_display":"748,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6117453,"accession":"0000899243-22-018913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018913","line_url":"/filing/0000899243-22-018913#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861878","owner_name":"YVER ANTOINE","owner_url":"/insider/0001861878","role":"Officer (EVP & Chairman of Development)","officer_title":"EVP & Chairman of Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20222.0,"shares_display":"20,222","price_per_share":5.4214,"price_display":"5.42","price_state":"stated","total_value":109631.5508,"total_display":"109,631.55","shares_owned_after":813675.0,"shares_owned_after_display":"813,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Officer (EVP & Chairman of Development)","n_filings":16,"first_seen":"2022-05-19","last_seen":"2023-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861878","retrieved_at":"2026-08-21T09:19:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}